(Reuters) – MetLife Inc said on Thursday it had signed a $19.20 billion reinsurance deal with retirement and life insurance firm Global Atlantic, and boosted its stock buyback programme to $4 bi[...]
Read more
Health
Medtronic’s profit forecast hit by stronger dollar, inflation
By Bhanvi Satija and Raghav Mahobe (Reuters) -Medtronic Plc on Thursday forecast annual profit below Wall Street estimates, as a strong U.S. dollar and persistently high costs of raw goods weighed on[...]
Read more
Boyu, Hillhouse, others vie for HK-based medical device firm Quasar -sources
By Kane Wu and Yantoultra Ngui HONG KONG (Reuters) – Private equity firms Boyu Capital, Hillhouse Capital and BPEA EQT are among bidders vying for Longreach Group’s Hong Kong-based medical[...]
Read more
Abbott, baby formula makers face FTC probe for potential collusion
(Reuters) -The U.S. Federal Trade Commission (FTC) is probing whether Abbott Laboratories and other companies that make baby formula colluded in bidding on state contracts, according to a document pos[...]
Read more
US business borrowing for equipment falls 8% in April- ELFA survey
(Reuters) – U.S. companies borrowed nearly 8% less in April than last year to finance equipment investments, industry body Equipment Leasing and Finance Association (ELFA) said on Wednesday. The[...]
Read more
Purdue Pharma to sell consumer business for $397 million
By Dietrich Knauth NEW YORK (Reuters) – Bankrupt Purdue Pharma received a U.S. judge’s permission on Tuesday to sell its consumer health business for $397 million to a subsidiary of Arcadi[...]
Read more
Judge tosses out some claims in Abbott baby formula litigation
By Jonathan Stempel (Reuters) – Abbott Laboratories persuaded a federal judge to dismiss some claims in nationwide litigation over recalled baby formula. In a decision on Monday, U.S. District J[...]
Read more
US judge hearing fight over Amgen deal for Horizon eyes September trial
CHICAGO (Reuters) – The judge who will decide if Amgen can go forward with its $27.8 billion purchase of Horizon Therapeutics on Tuesday said he was considering an evidentiary hearing on the mat[...]
Read more
Amgen settles patent lawsuit over biosimilar of J&J’s big-selling Stelara
By Blake Brittain (Reuters) -Johnson & Johnson has settled its lawsuit over Amgen Inc’s proposed biosimilar version of J&J’s top-selling treatment Stelara for psoriasis and other a[...]
Read more